[117th Congress Public Law 350]
[From the U.S. Government Publishing Office]
[[Page 6261]]
CHILDHOOD CANCER SURVIVORSHIP, TREATMENT, ACCESS, AND RESEARCH
REAUTHORIZATION ACT OF 2022
[[Page 136 STAT. 6262]]
Public Law 117-350
117th Congress
An Act
To maximize discovery, and accelerate development and availability, of
promising childhood cancer treatments, and for other
purposes. <<NOTE: Jan. 5, 2023 - [S. 4120]>>
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled, <<NOTE: Childhood Cancer
Survivorship, Treatment, Access, and Research Reauthorization Act of
2022.>>
SECTION 1. <<NOTE: 42 USC 201 note.>> SHORT TITLE.
This Act may be cited as the ``Childhood Cancer Survivorship,
Treatment, Access, and Research Reauthorization Act of 2022'' or the
``Childhood Cancer STAR Reauthorization Act''.
SEC. 2. REAUTHORIZING AND IMPROVING THE CHILDHOOD STAR ACT.
(a) Children's Cancer Biorepositories.--Section 417E of the Public
Health Service Act (42 U.S.C. 285a-11) is amended--
(1) in subsection (a)--
(A) in paragraph (2)(A), by inserting before the
period at the end of the second sentence the following:
``, such as collected samples of both solid tumor cancer
and paired samples'';
(B) in paragraph (9), by striking ``Childhood Cancer
Survivorship, Treatment, Access, and Research Act of
2018'' and inserting ``Childhood Cancer Survivorship,
Treatment, Access, and Research Reauthorization Act of
2022'';
(C) by redesignating paragraph (10) as paragraph
(11); and
(D) by inserting after paragraph (9) the following:
``(10) Report on researcher access to children's cancer
biorepository samples.--Not later than 2 years after the date of
enactment of the Childhood Cancer Survivorship, Treatment,
Access, and Research Reauthorization Act of 2022, the Director
of NIH shall--
``(A) <<NOTE: Review.>> conduct a review of the
procedures established under paragraph (2)(C) and other
policies or procedures related to researcher access to
such biospecimens to identify any opportunities to
reduce administrative burden, consistent with paragraph
(2)(D), in a manner that protects personal privacy to
the extent required by applicable Federal and State
privacy law, at a minimum; and
``(B) submit to the Committee on Health, Education,
Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives a
report on the findings of the review under subparagraph
(A) and whether the Director of NIH plans to make any
changes to the policies or procedures considered in such
review, based on such findings.''; and
[[Page 136 STAT. 6263]]
(2) in subsection (d), by striking ``2019 through 2023'' and
inserting ``2024 through 2028''.
(b) Cancer Survivorship Programs.--Section 201 of the Childhood
Cancer Survivorship, Treatment, Access, and Research Act of 2018 (Public
Law 115-180) <<NOTE: 42 USC 285a-11a note.>> is amended--
(1) in subsection (a)--
(A) in the subsection heading, by striking ``Pilot
Programs to Explore'' and inserting ``Research to
Evaluate''
(B) in paragraph (1)--
(i) by striking ``may make awards to eligible
entities to establish pilot programs'' and
inserting ``shall, as appropriate, make awards to
eligible entities to conduct or support
research'';
(ii) by striking ``model systems'' and
inserting ``approaches'';
(iii) by inserting ``and adolescent'' after
``childhood''; and
(iv) by striking ``evaluation of models for'';
(C) in paragraph (2)--
(i) in subparagraph (A), in the matter
preceding clause (i), by inserting ``within the
existing peer review process,'' after
``practicable,''; and
(ii) in subparagraph (B)(v), by striking ``in
treating survivors of childhood cancers'' and
inserting ``in carrying out the activities
described in paragraph (1)''; and
(D) in paragraph (3)(B)(v), by striking ``design of
systems for the effective transfer of treatment
information and care summaries from cancer care
providers to other health care providers'' and inserting
``design tools to support the secure electronic transfer
of treatment information and care summaries between
health care providers or, as applicable and appropriate,
longitudinal childhood cancer survivorship cohorts'';
and
(2) in subsection (b)--
(A) in each of paragraphs (1) and (2), by striking
``date of enactment of this Act'' and inserting ``date
of enactment of the Childhood Cancer Survivorship,
Treatment, Access, and Research Reauthorization Act of
2022''; and
(B) in paragraph (1)--
(i) by striking subparagraphs (A) and (C);
(ii) by redesignating subparagraph (B) as
subparagraph (A); and
(iii) by adding at the end the following:
``(B) recommendations for enhancing or promoting
activities of the Department of Health and Human
Services related to workforce development for health
care providers
[[Page 136 STAT. 6264]]
who provide psychosocial care to pediatric cancer
patients and survivors.''.
Approved January 5, 2023.
LEGISLATIVE HISTORY--S. 4120:
---------------------------------------------------------------------------
CONGRESSIONAL RECORD, Vol. 168 (2022):
Dec. 20, considered and passed Senate.
Dec. 22, considered and passed House.
<all>